Multimodal Augmented Reality for Operative Guidance in Interventional Neuroradiology
This research study explores the use of augmented reality (AR) to guide doctors during interventional neuroradiology procedures. These are minimally invasive treatments used for blood vessel problems in the brain, neck, and spine. Augmented reality can overlay 3D computer pictures, such as scans, directly into the specialist's view to help them navigate tiny blood vessels safely. Full details about the study plan, tests, and patient numbers are currently withheld with approval from the UK Health Research Authority (HRA). This standard process protects new technological developments while they are being tested. The complete study details and findings will be published within 30 months of the study ending. Patients having planned image-guided brain procedures at taking-part NHS hospitals may be invited to join by their medical team.
At a glance
What is this study about?
Interventional neuroradiology is a medical specialty where doctors treat problems in the blood vessels of the brain and spine without open surgery. Instead, they guide tiny, flexible tubes called catheters through blood vessels using live X-ray images. Because these vessels are very small and fragile, doctors need the clearest possible pictures to work safely.
This study is looking at augmented reality (AR) to give doctors an even better view. Augmented reality blends computer-generated 3D images—such as detailed scans taken before treatment—with the doctor's live view during the procedure. The goal is to help specialists see complex anatomy more clearly and guide their instruments with greater precision.
You might notice that detailed information about this trial is not yet public. The UK Health Research Authority (HRA) has granted a 'publication deferral'. This is an official agreement that lets researchers keep the exact details private for a limited time, usually to protect intellectual property or novel technology. Within 30 months after the research concludes, all details and results must be added to the public register.
Key takeaways
- The study tests augmented reality (AR) to guide delicate blood vessel procedures in the brain and spine.
- Full trial details are temporarily deferred with approval from the UK Health Research Authority (HRA).
- Complete trial information will be published within 30 months of the study's end date.
- The study is registered for all ages and all sexes having relevant procedures.
- Participation is entirely voluntary and will not impact your normal NHS care.
Who may be eligible?
The exact inclusion and exclusion rules have not been made public due to the temporary publication deferral. However, the title indicates the study is for patients who are due to have interventional neuroradiology procedures.
The trial record states that it includes all sexes and has no age limits. This means adults and potentially children could be considered, depending on the specific procedure.
If your local hospital is taking part in this research, your doctor or specialist nurse will check your medical records to see if you qualify and will discuss it with you directly.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- You are scheduled for an image-guided brain or spinal blood vessel procedure (interventional neuroradiology).
- You are being treated at an NHS hospital running this specific study.
- You are comfortable with new imaging and display tools being used during your care.
- Your specialist team has confirmed that this trial is suitable for your condition.
What does participation involve?
Because full study details are currently deferred, specific instructions about clinic visits, tests, and monitoring are not publicly available. In general, taking part in an imaging guidance trial means having your planned medical procedure as normal, while the team uses or tests the augmented reality system. You would continue to receive standard NHS care, and your doctors will closely monitor you before, during, and after treatment. Before deciding to join, you will receive a full information sheet explaining all appointments, tests, and how long you will be followed up.
Potential risks and benefits
Locations (1)
- Charing Cross HospitalApproximateLondon, England
Common questions
What is augmented reality in medicine?
Augmented reality (AR) is technology that adds helpful digital images, like 3D computer scans, onto what a doctor sees in real life during an operation.
Why are the study details kept private?
The UK Health Research Authority (HRA) has allowed details to be deferred temporarily. This is standard practice to protect new technology or research data until the study is complete.
When will the results be available?
Full details and study results must be published on the official trial register within 30 months after the research finishes.
Do I have to take part if my hospital is running the study?
No. Taking part in research is always your choice. If you decide not to take part, you will still receive the usual high standard of NHS care.
How can I find out if I am eligible?
You can ask your specialist or hospital consultant whether they are involved in this augmented reality research project.
How to find out more
Philip Pratt
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.